Dry Eye Disease
Conditions
Brief summary
The purpose of this study is to evaluate investigational ocular lubricants for their safety and tolerability on subjects with mild to moderate dry eye disease.
Detailed description
Subjects will be expected to attend a screening visit followed by 6 additional study visits. The expected duration of subject participation is approximately 3 weeks. This study will be conducted in Australia.
Interventions
Investigational ocular lubricant
OTHERFID123301 ocular lubricant
Investigational ocular lubricant
OTHERFID122505 ocular lubricant
Comparator ocular lubricant
Sponsors
Alcon Research
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Key Inclusion Criteria: * Sign an Informed Consent; * Have dry eye symptoms; * Other protocol-specified inclusion criteria may apply. Key
Exclusion criteria
* Ocular abnormalities; * Active ocular infection or inflammation not associated with dry eye; * History of ocular or intraocular surgery; * Other protocol-defined
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Best corrected visual acuity (BCVA) with manifest refraction, at distance | Day 1, each wear period. A wear period is 1 day. | BCVA will be collected for each eye individually and recorded in logarithm Minimum Angle of Resolution (logMAR) |
Countries
Australia
Outcome results
None listed